Keymed Biosciences (HKSE:02162) Operating Cash Flow per Share : HK$-1.27 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Operating Cash Flow per Share?

Keymed Biosciences's operating cash flow per share for the six months ended in Dec. 2023 was HK$-1.44. Keymed Biosciences's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-1.27.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Keymed Biosciences's Operating Cash Flow per Share or its related term are showing as below:

HKSE:02162' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -82.9 Med: -58.7 Max: -34.5
Current: -34.5

During the past 5 years, Keymed Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was -34.50% per year. The lowest was -82.90% per year. And the median was -58.70% per year.

HKSE:02162's 3-Year OCF Growth Rate is ranked worse than
83.37% of 1233 companies
in the Biotechnology industry
Industry Median: 3.5 vs HKSE:02162: -34.50

Keymed Biosciences Operating Cash Flow per Share Historical Data

The historical data trend for Keymed Biosciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Operating Cash Flow per Share Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-0.28

-0.52

-1.63

-1.72

-1.27

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-0.57	-0.73	-1.01	0.16	-1.44

Competitive Comparison of Keymed Biosciences's Operating Cash Flow per Share

For the Biotechnology subindustry, Keymed Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keymed Biosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's Price-to-Operating-Cash-Flow falls into.

Keymed Biosciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Keymed Biosciences's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-332.093	/	261.368
	=	-1.27

Keymed Biosciences's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-375.453	/	261.450
	=	-1.44

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1.27

Keymed Biosciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences (HKSE:02162) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

64Z:Germany

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.

Executives

Chen Bo	2201 Interest of corporation controlled by you
Eagle Hero Management Limited	2101 Beneficial owner
Trident Trust Company (hk) Limited	2301 Trustee
Moonshot Holdings Limited	2101 Beneficial owner
Hh Kny Holdings Limited
Hillhouse Investment Management, Ltd.
Boyu Capital Group Holdings Ltd
Xyxy Holdings Ltd.
Tong Xiaomeng

Keymed Biosciences (HKSE:02162) Headlines

No Headlines